Cargando…
The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
BACKGROUND: Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however case reports have show effectiveness with lower doses. The objective of the current study was to determine in men with benign prostatic...
Autores principales: | Sullivan, Michael J, Geller, Jack |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65043/ https://www.ncbi.nlm.nih.gov/pubmed/11818031 http://dx.doi.org/10.1186/1471-2490-2-2 |
Ejemplares similares
-
Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016) -
Short-term Effect of Tamsulosin and Finasteride Monotherapy and their Combination on Nigerian Men with Benign Prostatic Hyperplasia
por: Odusanya, Benjamin O, et al.
Publicado: (2017) -
Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs
por: Angrimani, Daniel S. R., et al.
Publicado: (2020) -
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
por: Smith, Angela B, et al.
Publicado: (2009) -
Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
por: Shin, Yu Seob, et al.
Publicado: (2019)